A phase II study: dose-dense carboplatin and paclitaxel as neoadjuvant chemotherapy in locally advanced cervical cancer

References

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
   PubMed Web of Science ®Google Scholar
• Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999;340(15):1137–43.
   PubMed Web of Science ®Google Scholar
• Peters WA III, Liu PY, Barrett RJ II, Stock RJ, Monk BJ, Berek JS, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18(8):1606–13.
   PubMed Web of Science ®Google Scholar
• Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340(15):1144–53
   PubMed Web of Science ®Google Scholar
• Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC Jr, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol. 1999;17(5):1339–48.
   PubMed Web of Science ®Google Scholar
• Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL III, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999;340(15):1154–61.
   PubMed Web of Science ®Google Scholar
• Iwata T, Miyauchi A, Suga Y, Nishio H, Nakamura M, Ohno A, et al. Neoadjuvant chemotherapy for locally advanced cervical cancer. Chin J Cancer Res. 2016;28(2):235–40.
   PubMed Web of Science ®Google Scholar
• Angioli R, Plotti F, Montera R, Aloisi A, Luvero D, Capriglione S, et al. Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer. Gynecol Oncol. 2012;127:290–6.
   PubMed Web of Science ®Google Scholar
• Zhang H, Peng W, Zhang Y. Detection of cell apoptosis in pelvic lymph nodes of patients with cervical cancer after neoadjuvant chemotherapy. J Int Med Res. 2014;42:641–50.
   PubMed Web of Science ®Google Scholar
• Basile S, Angioli R, Manci N, Manci N, Palaia I, Benedetti Panici P, et al. Gynecological cancers in developing countries: the challenge of chemotherapy in low-resources setting. Int J Gynecol Cancer. 2006;16:1491–7.
   PubMed Web of Science ®Google Scholar
• Bonomi P, Blessing JA, Stehman FB, DiSaia PJ, Walton L, Major FJ. Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 1985;3:1079–85.
   PubMed Web of Science ®Google Scholar
• Omura GA, Blessing Ja, Vaccarello L, Berman ML, Clarke-Pearson DL, Mutch DG, et al: Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol. 1997;15:165–71,
   PubMed Web of Science ®Google Scholar
• Vermoken JB, Zanetta G, De Oliveira CF, van der Burg MEL, Lacave AJ, Teodorovic I, et al: Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma of the uterine cervix: an EORTC Gynecological Cancer Cooperative Group study. Ann Oncol. 2001;12 (7):967–74.
   PubMed Web of Science ®Google Scholar
• Thierne J; Metanalysis Group. Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials. Eur J Cancer. 2003;39:2470–86.
   PubMed Web of Science ®Google Scholar
• Minig L, Colombo N, Zanagnolo V, Landoni F, Bocciolone L, Cárdenas-Rebollo JM, et al. Platinum-based neoadjuvant chemotherapy followed by radical surgery for cervical carcinoma international federation of gynecology and obstetrics stage IB2-IIB. Int J Gynecol Cancer. 2013;23(9):1647–54.
   PubMed Web of Science ®Google Scholar
• Selvaggi L, Loizzi V, Di Gilio AR, Nardelli C, Cantatore C, Cormio G. Neoadjuvant chemotherapy in cervical cancer: a 67 patients experience. Int J Gynecol Cancer. 2006;16(6):2044–8.
   PubMedGoogle Scholar
• Pignata S, Silvestro G, Ferrari E, Selvaggi L, Perrone F, Maffeo A, et al. Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervix. J Clin Oncol. 1999;17(3):756–60
   PubMed Web of Science ®Google Scholar
• Di Vagno G, Cormio G, Pignata S, Scambia G, Di Stefano MG, Tambaro R, et al. Cisplatin and vinorelbine as neoadjuvant chemotherapy in locally advanced cervical cancer: a phase II study. Int J Gynecol Cancer. 2003;13(3):308–12.
   PubMed Web of Science ®Google Scholar
• Benedetti Pacini P, Scambia G, Baiocchi G, Greggi S, Ragusa G, Gallo A, et al. Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Prognostic factors for response and survival. Cancer. 1991;67(2):372–9.
   PubMed Web of Science ®Google Scholar
• Loizzi V, Cormio G, Vicino M, Selvaggi L. Neoadjuvant chemotherapy: an alternative option of treatment for locally advanced cervical cancer. Gynecol Obstet Invest. 2008;65(2):96–103. Review
   PubMed Web of Science ®Google Scholar
• Loizzi V, Cormio G, Loverro G, Selvaggi L, Disaia PJ, Cappuccini F. Chemoradiation: a new approach for the treatment of cervical cancer. Int J Gynecol Cancer. 2003;13(5):580–6. Review.
   PubMed Web of Science ®Google Scholar
• Kim HS, Sardi JE, Katsumata N, Ryu HS, Nam JH, Chung HH, et al. Efficacy of neoadjuvant chemotherapy in patients with FIGO stage IB1 to IIA cervical cancer: an international collaborative meta-analysis. Eur J Surg Oncol. 2013;39(2):115–24
   PubMed Web of Science ®Google Scholar
• Zanaboni F, Grijuela B, Giudici S, Cormio G, Babilonti L, Ghezzi F, et al. Weekly topotecan and cisplatin (TOPOCIS) as neo-adjuvant chemotherapy for locally-advanced squamous cervical carcinoma: Results of a phase II multicentric study. Eur J Cancer. 2013;49(5):1065–72.
   PubMed Web of Science ®Google Scholar
• Buda A, Fossati R, Colombo N, Fei F, Floriani I, Gueli Alletti D, et al. Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study. J Clin Oncol. 2005;23(18):4137–45.
   PubMed Web of Science ®Google Scholar
• Lissoni AA, Colombo N, Pellegrino A, Parma G, Zola P, Katsaros D, et al. A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study. Ann Oncol. 2009;20(4):660–5.
   PubMed Web of Science ®Google Scholar
• Shimada M, Nagao S, Fujiwara K, Takeshima N, Takizawa K, Shoji T, et al. Neoadjuvant chemotherapy with docetaxel and carboplatin followed by radical hysterectomy for stage IB2, IIA2, and IIB patients with non-squamous cell carcinoma of the uterine cervix. Int J Clin Oncol. 2016;21(6):1128–35.
   PubMed Web of Science ®Google Scholar
• Shoji T, Takatori E, Furutake Y, Takada A, Nagasawa T, Omi H, et al. Phase II clinical study of neoadjuvant chemotherapy with CDDP/CPT-11 regimen in combination with radical hysterectomy for cervical cancer with a bulky mass. Int J Clin Oncol. 2016;21(6):1120–7.
   PubMed Web of Science ®Google Scholar